**
Research from the University of Edinburgh reveals that individuals suffering from hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS) in the UK endure an alarming wait for diagnosis, with some waiting as long as 21 years. The study, which surveyed over 2,000 participants, underscores a troubling lack of awareness among healthcare professionals regarding these complex conditions, leading to a fragmented and often inadequate healthcare experience for those affected.
Long Waits for Diagnosis
The findings illuminate a stark reality: individuals with hypermobility conditions are often left in the dark about their health for decades. Symptoms can include chronic pain, joint dislocations, fatigue, and a host of neurological or gastrointestinal issues. The research indicates that the average wait for a diagnosis varies by region, with Welsh respondents reporting an excruciating average of 21.7 years, followed by Northern Ireland at 21.1 years, Scotland at 19.5 years, and England at 19 years.
This extensive delay can exacerbate the already challenging symptoms of these disorders. Kathryn Berg, trial and data manager at the University of Edinburgh’s Institute of Genetics and Cancer, stated, “This study highlights the profound impact hEDS and HSD can have across every aspect of life. Our findings show the urgent need for equitable, multidisciplinary care pathways that recognise the complex and multisystemic nature of these conditions.”
The Impact on Daily Life
The repercussions of such long diagnostic delays are far-reaching. Nearly half of the respondents reported unemployment, with 46% relying on disability benefits. Educational disruptions were also common, with 56% indicating that their schooling had been significantly affected. The toll on mental health is equally concerning, with 71% of participants experiencing anxiety, 63% suffering from depression, and over half dealing with debilitating migraines.
Notably, the survey highlighted that a significant portion of respondents had to travel long distances to receive a proper diagnosis, particularly in Wales and Northern Ireland. Over a third of respondents from these regions had sought assessments in other parts of the UK, reflecting a significant barrier to timely and appropriate care.
A Call for Change
The lack of awareness among healthcare professionals regarding hypermobility disorders has been a recurrent theme in patient experiences. High-profile figures, such as writer and actress Lena Dunham, have shared their own struggles to receive a proper diagnosis. Dunham recounted how her symptoms were often dismissed as mere quirks until she was finally diagnosed in her late 20s. Her story sheds light on the broader societal issue of how women’s health concerns are often neglected or trivialised.
In response to the findings, a spokesperson from the Welsh government acknowledged the challenges faced by patients and indicated that efforts are underway to develop a “draft community health pathway” aimed at improving diagnosis and care access. Similarly, a UK government representative noted the importance of recognising and addressing the needs of individuals living with these conditions, emphasising the role of the Royal College of General Practitioners in improving clinician awareness.
Why it Matters
The chronic delays in diagnosing hypermobility spectrum disorders not only undermine the wellbeing of those affected but also highlight a systemic failure within the healthcare framework. These findings call for urgent reforms to ensure equitable access to care and greater awareness among health professionals. Addressing these gaps is essential not only for improving individual health outcomes but also for fostering a healthcare system that genuinely prioritises patient needs, particularly for those with complex and often invisible conditions.
